vancomycin has been researched along with panipenem in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Domon, H; Fukuoka, T; Hirasawa, A; Ishii, C; Kakuta, M; Ohya, S; Utsui, Y; Yasuda, H | 1 |
Kimpara, I; Kudo, E; Kudo, H; Kudo, Y; Miura, T; Saitoh, Y; Sato, S; Tsujino, M | 2 |
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
Kimura, T; Kubo, H; Matsuura, N; Shimada, S; Sunakawa, K; Yago, K | 1 |
Sakata, H | 1 |
1 trial(s) available for vancomycin and panipenem
Article | Year |
---|---|
Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Creatinine; Dibekacin; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Male; Models, Biological; Population; Thienamycins; Vancomycin | 2004 |
6 other study(ies) available for vancomycin and panipenem
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Burns; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Drug Synergism; Hexosyltransferases; Methicillin Resistance; Mice; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
[In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Topics: Anti-Bacterial Agents; Carbapenems; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
[In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Topics: Carbapenems; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Hydrogen-Ion Concentration; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1998 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
[Antimicrobial susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae isolated from children with meningitis].
Topics: Ampicillin; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Infant; Meningitis; Meropenem; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2004 |